Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia This study aims to assess the cost-effectiveness and budget impact of adopting sildenafil to the benefits package for the indication of pulmonary arterial hypertension (PAH), compared to beraprost. Read the full article ›